PATIENT MONITORING RECOMMENDATIONS

Given the limited experience with remdesivir at the recommended dose and duration, patients should have appropriate clinical and laboratory monitoring to aid in early detection of any potential adverse events while receiving remdesivir. The following laboratory tests should be performed daily while receiving remdesivir: serum chemistries, hematology, ALT, AST, bilirubin, and alkaline phosphatase; renal function tests (creatinine and creatinine clearance).

DESREM™, Remdesivir Prescribing Information. Mylan Laboratories Limited. 2020.

India Health Care Professional

Health Care Professional Outside India

This website is for Healthcare Professionals only.

Please confirm if you are a healthcare professional.

Yes, I am

Disclaimer: Mylan, a Viatris company does not recommend the use of its product Desrem^™ (Remdesivir for injection 100mg/vial, hereinafter, the “Product”) in any manner inconsistent with that described in the full prescribing information. The data contained in this microsite is for medical and scientific informational purposes only. Information presented on the microsite should not be construed as advice or recommendation for using the Product. Mylan, a Viatris company expressly disclaims liability for any undue consequences arising out of off-label use of the Product. Mylan, a Viatris company or any of its affiliates, directors, employees, officers, consultants, service providers shall not be responsible in any manner whatsoever, for any action taken, opinions expressed, advice rendered or accepted, any direct, incidental, special or consequential loss and damage caused on the basis of any material or information presented on this microsite. Please refer to full prescribing information before prescribing the Product.